With resistance to antibiotics growing in the U.S., startups around the world are seeking new ways to target and treat bacteria-associated diseases. One example is Paris-based Eligo Bioscience, which targets the microbiome — microorganisms that live in the gut, vagina, lung, and on the skin. The startup has garnered considerable interest, managing to lock in […]
